mHealth for Sexually Transmitted Infections
Trial Summary
What is the purpose of this trial?
We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the mHealth Intervention treatment for sexually transmitted infections?
Research shows that mobile health (mHealth) interventions, like those using mobile phones, can improve sexual health outcomes by increasing STI testing and reducing risky behaviors, such as alcohol use, in young people. These interventions have been effective in promoting sexual health education and behavior change, which are crucial for preventing STIs.12345
Is mHealth for sexually transmitted infections safe for humans?
The research on mHealth interventions for sexually transmitted infections primarily focuses on their effectiveness in improving sexual health knowledge and behavior. There is no specific mention of safety concerns, suggesting that these digital interventions are generally considered safe for human use.36789
How is the mHealth Intervention treatment for sexually transmitted infections different from other treatments?
The mHealth Intervention is unique because it uses mobile phone technology to deliver educational content and promote safe sexual practices, making it more accessible and engaging, especially for young people. Unlike traditional treatments that focus on medication, this approach emphasizes prevention and behavior change through digital means.123610
Research Team
Monika Goyal, MD
Principal Investigator
Children's National Research Institute
Eligibility Criteria
This trial is for adolescent patients who have tested positive for gonorrhea, chlamydia, or pelvic inflammatory disease in the Emergency Department and are prescribed outpatient antibiotics.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive STI treatment with adherence monitored through text messages or usual care
Follow-up
Participants are monitored for STI treatment adherence and receipt after treatment
Treatment Details
Interventions
- mHealth Intervention (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's National Research Institute
Lead Sponsor